Analgesic use during pregnancy and risk of infant leukaemia: A Children's Oncology Group study

9Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Infant leukaemia is likely initiated in utero. Methods: We examined whether analgesic use during pregnancy was associated with risk by completing telephone interviews of the mothers of 441 infant leukaemia cases and 323 frequency-matched controls, using unconditional logistic regression. Results: With the exception of a reduced risk for infant acute myeloid leukaemias with non-aspirin non-steroidal anti-inflammatory drugs (NSAID) use early in pregnancy (odds ratios=0.60; confidence intervals: 0.37-0.97), no statistically significant associations were observed for aspirin, non-aspirin NSAIDs, or acetaminophen use in early pregnancy or after knowledge of pregnancy. Conclusion: Overall, analgesic use during pregnancy was not significantly associated with the risk of infant leukaemia. © 2011 Cancer Research UK All rights reserved.

Cite

CITATION STYLE

APA

Ognjanovic, S., Blair, C., Spector, L. G., Robison, L. L., Roesler, M., & Ross, J. A. (2011). Analgesic use during pregnancy and risk of infant leukaemia: A Children’s Oncology Group study. British Journal of Cancer, 104(3), 532–536. https://doi.org/10.1038/sj.bjc.6606046

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free